张康
下載導師簡歷CV
Section 1: Personal Particulars
张康
Kang Zhang
Professor
18063928758
kzhang@must.edu.mo
澳門科技大學
澳門科技大學-醫學院
Vice Dean, Faculty of Medicine
Research Project provided for Macao Youth Scholars Program:
基於時序電子病歷與眼底影像的多模態融合眼科及全身性疾病智能預測研究
Multimodal Fusion of Longitudinal EHRs Fundus Images for the Intelligent Prediction of Ocular and Systemic Diseases
1002 临床医学
0701 数学,0809 电子科学与技术,0812 计算机科学与技术,0831 生物医学工程,0836 生物工程,1005 中医学,1006 中西医结合,1007 药学,1008 中药学
1. Research experience in medical image analysis, multimodal data fusion, or Large Language Models (LLMs). 2. Experience in open-source project contributions or code reproduction. 3. Experience in interdisciplinary collaboration, with the ability to communicate effectively with medical and clinical researchers. 4. Experience in using GPU clusters and training large-scale models. 5.Published papers as a first author or co-first author in top-tier international journals or conferences in the field
Ph.D., Genetics, Harvard University; M.D., Harvard University (Harvard-MIT HST); Postdoc, Harvard Medical School; Residency, Johns Hopkins University (Wilmer Eye Institute)
Professor Zhang has authored over 400 Web of Science-indexed publications, with nearly 300 in top-tier journals such as Nature, Science, Cell, and The New England Journal of Medicine. His work has been cited over 80,000 times, and he has an H-index of 114. His sustained scholarly impact is demonstrated by his consistent recognition as a Clarivate "Global Highly Cited Researcher" from 2019 to 2024. Professor Zhang's research has been highlighted by major international awards and selections, including Science Magazine's "Top 10 Scientific Breakthroughs of the Year" (2006) and Nature Medicine's "Notable Advances in Life Sciences" (2016). His work has also been featured on the cover of Cell and named its "Best Paper of the Year" (2018), and honored as Cell's "Best Cross-Disciplinary Paper in China" (2020). He has been elected a fellow of numerous prestigious organizations, including the American Association for the Advancement of Science (AAAS), the American Institute for Medical and Biological Engineering (AIMBE), the American Society for Clinical Investigation (ASCI), and the Association of American Physicians (AAP). He is also a fellow of the Royal Society of Medicine (UK) and the Royal Society of Chemistry (UK). He is a founding Co-Editor-in-Chief of Signal Transduction and Targeted Therapy (STTT). His other honors include the "Chang Jiang Scholar" award, the World Chinese Medical Association "Henry Fok" Award, and recognition as one of "America's Best Ophthalmologists." He is an inventor on over 20 granted U.S. patents.
Section 2: Research Interests and Grants
Medical Artificial Intelligence (AI)、Ophthalmology、Oncology、Molecular Genetics、Precision Medicine
8
7
1
Funding Expenditure of the Macau Institute for AI in Medicine